Paranoia as a deficit in non-social belief updating

  1. Erin J Reed
  2. Stefan Uddenberg
  3. Praveen Suthaharan
  4. Christoph D Mathys
  5. Jane R Taylor
  6. Stephanie Mary Groman
  7. Philip R Corlett  Is a corresponding author
  1. Yale University, United States
  2. Princeton University, United States
  3. Scuola Internazionale Superiore di Studi Avanzati (SISSA), Italy

Abstract

Paranoia is the belief that harm is intended by others. It may arise from selective pressures to infer and avoid social threats, particularly in ambiguous or changing circumstances. We propose that uncertainty may be sufficient to elicit learning differences in paranoid individuals, without social threat. We used reversal learning behavior and computational modeling to estimate belief updating across individuals with and without mental illness, online participants, and rats chronically exposed to methamphetamine, an elicitor of paranoia in humans. Paranoia is associated with a stronger prior on volatility, accompanied by elevated sensitivity to perceived changes in the task environment. Methamphetamine exposure in rats recapitulates this impaired uncertainty-driven belief updating and rigid anticipation of a volatile environment. Our work provides evidence of fundamental, domain-general learning differences in paranoid individuals. This paradigm enables further assessment of the interplay between uncertainty and belief-updating across individuals and species.

Data availability

Data are available on ModelDB83 (http://modeldb.yale.edu/258631) with accession code p2c8q74m. Figures 2-10 have associated raw data available. Code for the HGF toolbox v5.3.1 is freely available at https://translationalneuromodeling.github.io/tapas/.

Article and author information

Author details

  1. Erin J Reed

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Stefan Uddenberg

    Neuroscience Institute, Princeton University, New Jersey, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Praveen Suthaharan

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Christoph D Mathys

    Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy
    Competing interests
    The authors declare that no competing interests exist.
  5. Jane R Taylor

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Stephanie Mary Groman

    Psychiatry, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5231-0612
  7. Philip R Corlett

    Psychiatry, Yale University, New Haven, United States
    For correspondence
    philip.corlett@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5368-1992

Funding

NIMH (R01MH12887)

  • Philip R Corlett

NIMH (R21MH120799-01)

  • Stephanie Mary Groman
  • Philip R Corlett

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Geoffrey Schoenbaum, National Institute on Drug Abuse, National Institutes of Health, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) at Yale University

Human subjects: Experiments were conducted at Yale University and the Connecticut Mental Health Center (New Haven, CT) in strict accordance with Yale University's Human Investigation Committee and Institutional Animal Care and Use Committee. Informed consent was provided by all research participants (Yale HIC# 2000022111: Beliefs and Personality Traits)

Version history

  1. Received: February 24, 2020
  2. Accepted: May 22, 2020
  3. Accepted Manuscript published: May 26, 2020 (version 1)
  4. Accepted Manuscript updated: May 27, 2020 (version 2)
  5. Version of Record published: June 30, 2020 (version 3)
  6. Version of Record updated: July 7, 2020 (version 4)

Copyright

© 2020, Reed et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,099
    Page views
  • 742
    Downloads
  • 54
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Erin J Reed
  2. Stefan Uddenberg
  3. Praveen Suthaharan
  4. Christoph D Mathys
  5. Jane R Taylor
  6. Stephanie Mary Groman
  7. Philip R Corlett
(2020)
Paranoia as a deficit in non-social belief updating
eLife 9:e56345.
https://doi.org/10.7554/eLife.56345

Share this article

https://doi.org/10.7554/eLife.56345

Further reading

    1. Developmental Biology
    2. Neuroscience
    Tariq Zaman, Daniel Vogt ... Michael R Williams
    Research Article

    The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.

    1. Neuroscience
    Hideo Hagihara, Hirotaka Shoji ... Tsuyoshi Miyakawa
    Research Article

    Increased levels of lactate, an end-product of glycolysis, have been proposed as a potential surrogate marker for metabolic changes during neuronal excitation. These changes in lactate levels can result in decreased brain pH, which has been implicated in patients with various neuropsychiatric disorders. We previously demonstrated that such alterations are commonly observed in five mouse models of schizophrenia, bipolar disorder, and autism, suggesting a shared endophenotype among these disorders rather than mere artifacts due to medications or agonal state. However, there is still limited research on this phenomenon in animal models, leaving its generality across other disease animal models uncertain. Moreover, the association between changes in brain lactate levels and specific behavioral abnormalities remains unclear. To address these gaps, the International Brain pH Project Consortium investigated brain pH and lactate levels in 109 strains/conditions of 2294 animals with genetic and other experimental manipulations relevant to neuropsychiatric disorders. Systematic analysis revealed that decreased brain pH and increased lactate levels were common features observed in multiple models of depression, epilepsy, Alzheimer’s disease, and some additional schizophrenia models. While certain autism models also exhibited decreased pH and increased lactate levels, others showed the opposite pattern, potentially reflecting subpopulations within the autism spectrum. Furthermore, utilizing large-scale behavioral test battery, a multivariate cross-validated prediction analysis demonstrated that poor working memory performance was predominantly associated with increased brain lactate levels. Importantly, this association was confirmed in an independent cohort of animal models. Collectively, these findings suggest that altered brain pH and lactate levels, which could be attributed to dysregulated excitation/inhibition balance, may serve as transdiagnostic endophenotypes of debilitating neuropsychiatric disorders characterized by cognitive impairment, irrespective of their beneficial or detrimental nature.